Literature DB >> 25781447

Reporting of noninferiority trials in ClinicalTrials.gov and corresponding publications.

Anand D Gopal1, Nihar R Desai2, Tony Tse3, Joseph S Ross2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25781447      PMCID： PMC5897692          DOI： 10.1001/jama.2015.1697

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Quality of reporting of noninferiority and equivalence randomized trials.

Authors:  Anne Le Henanff; Bruno Giraudeau; Gabriel Baron; Philippe Ravaud
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

2.  Lessons from and cautions about noninferiority and equivalence randomized trials.

Authors:  Peter C Gøtzsche
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

3.  Reporting of noninferiority trials was incomplete in trial registries.

Authors:  Olaf M Dekkers; Darius Soonawala; Jan P Vandenbroucke; Matthias Egger
Journal:  J Clin Epidemiol       Date:  2011-03-27       Impact factor: 6.437

4.  The ClinicalTrials.gov results database--update and key issues.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Robert M Califf; Nicholas C Ide
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

5.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Stuart J Pocock; Stephen J W Evans; Douglas G Altman
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 6.  Through the looking glass: understanding non-inferiority.

Authors:  Jennifer Schumi; Janet T Wittes
Journal:  Trials       Date:  2011-05-03       Impact factor: 2.279
  6 in total
  6 in total

1.  Update on Trial Registration 11 Years after the ICMJE Policy Was Established.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Thiyagu Rajakannan
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

2.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

3.  ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.

Authors:  Lisa M Schwartz; Steven Woloshin; Eugene Zheng; Tony Tse; Deborah A Zarin
Journal:  Ann Intern Med       Date:  2016-06-14       Impact factor: 25.391

4.  Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.

Authors:  Robert D Beckett; Kathryn C Loeser; Kathryn R Bowman; Trent G Towne
Journal:  BMC Med Res Methodol       Date:  2016-08-24       Impact factor: 4.615

5.  How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider.

Authors:  Tony Tse; Kevin M Fain; Deborah A Zarin
Journal:  BMJ       Date:  2018-05-25

6.  Surgical clinical trials with non-inferiority design: a cross-sectional bibliometric analysis.

Authors:  Chi Shu; Bin Huang; Ding Yuan; Yi Yang; Xiaojiong Du; Yazhou He; Xin Chen; Jichun Zhao
Journal:  Ann Transl Med       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.